Company Search:
Advanced Search
Sponsored Links
Amicus Therapeutics, Inc Company Snapshot
Amicus Therapeutics, Inc operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Amicus Therapeutics, Inc with three other companies in this sector in the United States: ArQule, Inc. (2016 sales of $4.71 million of which 100% was Chemical Compounds), Tetraphase Pharmaceuticals Inc ($5.15 million of which 100% was Biopharmaceuticals), and Innovus Pharmaceuticals Inc ($4.82 million ).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Amicus Therapeutics, Inc
  Stock Performance Chart for Amicus Therapeutics, Inc
  Stock Data: Recent Stock Performance:
  Current Price (1/12/2018): 15.72
(Figures in U.S. Dollars)
1 Week 5.4%   13 Weeks 22.3%  
4 Weeks 8.2%   52 Weeks 164.2%  
Amicus Therapeutics, Inc Key Data:
  Ticker: FOLD Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 4,958,000
(Year Ending Jan 2017).
Employees: 263
  Currency: U.S. Dollars Market Cap: 2,613,753,396
  Fiscal Yr Ends: December Shares Outstanding: 166,269,300
  Share Type: Common Closely Held Shares: 935,078
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.